Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment significantly improved hair density and regrowth in both men and women suffering from pattern hair loss, with even better results when combined with certain medications.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

Aging significantly affects the hair and scalp of nonbalding Caucasian women, with changes that differ from male pattern baldness.

Two cosmetic lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Classifying curl patterns might help doctors assess and treat hair loss better.

Women using 5% minoxidil for hair loss were mostly satisfied and had improved quality of life, despite some impact on social life and hairstyle choices.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Androgen levels do not determine the type of PCOS symptoms in young females.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Female androgenetic alopecia affects many women, is reversible with treatment like Minoxidil, and has significant psychological impacts.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Genetics and hormones cause hair loss; finasteride treats it safely.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The most common causes of hair loss in a Nigerian hospital were discoid lupus erythematosus of the scalp and alopecia areata, and more research is needed to understand and address these issues.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.